Article info
PDFOriginal research
Exercise prehabilitation during neoadjuvant chemotherapy may enhance tumour regression in oesophageal cancer: results from a prospective non-randomised trial
- Correspondence to Andrew Davies, Gastrointestinal Medicine and Surgery, Guy's and St Thomas' Hospitals NHS Trust, London SE1 7EH, UK; Andrew.Davies1{at}gstt.nhs.uk
Citation
Exercise prehabilitation during neoadjuvant chemotherapy may enhance tumour regression in oesophageal cancer: results from a prospective non-randomised trial
Publication history
- Accepted December 6, 2021
- First published February 1, 2022.
Online issue publication
October 11, 2022
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.